Behavioral and neurocognitive factors distinguishing post-traumatic stress comorbidity in substance use disorders

Abstract Significant trauma histories and post-traumatic stress disorder (PTSD) are common in persons with substance use disorders (SUD) and often associate with increased SUD severity and poorer response to SUD treatment. As such, this sub-population has been associated with unique risk factors and...

Full description

Bibliographic Details
Main Authors: David C. Houghton, Heidi M. Spratt, Lori Keyser-Marcus, James M. Bjork, Gretchen N. Neigh, Kathryn A. Cunningham, Tatiana Ramey, F. Gerard Moeller
Format: Article
Language:English
Published: Nature Publishing Group 2023-09-01
Series:Translational Psychiatry
Online Access:https://doi.org/10.1038/s41398-023-02591-3
_version_ 1797556254345789440
author David C. Houghton
Heidi M. Spratt
Lori Keyser-Marcus
James M. Bjork
Gretchen N. Neigh
Kathryn A. Cunningham
Tatiana Ramey
F. Gerard Moeller
author_facet David C. Houghton
Heidi M. Spratt
Lori Keyser-Marcus
James M. Bjork
Gretchen N. Neigh
Kathryn A. Cunningham
Tatiana Ramey
F. Gerard Moeller
author_sort David C. Houghton
collection DOAJ
description Abstract Significant trauma histories and post-traumatic stress disorder (PTSD) are common in persons with substance use disorders (SUD) and often associate with increased SUD severity and poorer response to SUD treatment. As such, this sub-population has been associated with unique risk factors and treatment needs. Understanding the distinct etiological profile of persons with co-occurring SUD and PTSD is therefore crucial for advancing our knowledge of underlying mechanisms and the development of precision treatments. To this end, we employed supervised machine learning algorithms to interrogate the responses of 160 participants with SUD on the multidimensional NIDA Phenotyping Assessment Battery. Significant PTSD symptomatology was correctly predicted in 75% of participants (sensitivity: 80%; specificity: 72.22%) using a classification-based model based on anxiety and depressive symptoms, perseverative thinking styles, and interoceptive awareness. A regression-based machine learning model also utilized similar predictors, but failed to accurately predict severity of PTSD symptoms. These data indicate that even in a population already characterized by elevated negative affect (individuals with SUD), especially severe negative affect was predictive of PTSD symptomatology. In a follow-up analysis of a subset of 102 participants who also completed neurocognitive tasks, comorbidity status was correctly predicted in 86.67% of participants (sensitivity: 91.67%; specificity: 66.67%) based on depressive symptoms and fear-related attentional bias. However, a regression-based analysis did not identify fear-related attentional bias as a splitting factor, but instead split and categorized the sample based on indices of aggression, metacognition, distress tolerance, and interoceptive awareness. These data indicate that within a population of individuals with SUD, aberrations in tolerating and regulating aversive internal experiences may also characterize those with significant trauma histories, akin to findings in persons with anxiety without SUD. The results also highlight the need for further research on PTSD-SUD comorbidity that includes additional comparison groups (i.e., persons with only PTSD), captures additional comorbid diagnoses that may influence the PTSD-SUD relationship, examines additional types of SUDs (e.g., alcohol use disorder), and differentiates between subtypes of PTSD.
first_indexed 2024-03-10T17:00:12Z
format Article
id doaj.art-b91ebe37a8a544f59a9f51327adb1981
institution Directory Open Access Journal
issn 2158-3188
language English
last_indexed 2024-03-10T17:00:12Z
publishDate 2023-09-01
publisher Nature Publishing Group
record_format Article
series Translational Psychiatry
spelling doaj.art-b91ebe37a8a544f59a9f51327adb19812023-11-20T11:00:41ZengNature Publishing GroupTranslational Psychiatry2158-31882023-09-0113111110.1038/s41398-023-02591-3Behavioral and neurocognitive factors distinguishing post-traumatic stress comorbidity in substance use disordersDavid C. Houghton0Heidi M. Spratt1Lori Keyser-Marcus2James M. Bjork3Gretchen N. Neigh4Kathryn A. Cunningham5Tatiana Ramey6F. Gerard Moeller7Center for Addiction Sciences and Therapeutics, University of Texas Medical BranchCenter for Addiction Sciences and Therapeutics, University of Texas Medical BranchInstitute for Drug and Alcohol Studies, Virginia Commonwealth UniversityInstitute for Drug and Alcohol Studies, Virginia Commonwealth UniversityDepartment of Anatomy and Neurobiology, Virginia Commonwealth UniversityCenter for Addiction Sciences and Therapeutics, University of Texas Medical BranchDivision of Therapeutics and Medical Consequences, National Institute of Drug Abuse, National Institutes of HealthInstitute for Drug and Alcohol Studies, Virginia Commonwealth UniversityAbstract Significant trauma histories and post-traumatic stress disorder (PTSD) are common in persons with substance use disorders (SUD) and often associate with increased SUD severity and poorer response to SUD treatment. As such, this sub-population has been associated with unique risk factors and treatment needs. Understanding the distinct etiological profile of persons with co-occurring SUD and PTSD is therefore crucial for advancing our knowledge of underlying mechanisms and the development of precision treatments. To this end, we employed supervised machine learning algorithms to interrogate the responses of 160 participants with SUD on the multidimensional NIDA Phenotyping Assessment Battery. Significant PTSD symptomatology was correctly predicted in 75% of participants (sensitivity: 80%; specificity: 72.22%) using a classification-based model based on anxiety and depressive symptoms, perseverative thinking styles, and interoceptive awareness. A regression-based machine learning model also utilized similar predictors, but failed to accurately predict severity of PTSD symptoms. These data indicate that even in a population already characterized by elevated negative affect (individuals with SUD), especially severe negative affect was predictive of PTSD symptomatology. In a follow-up analysis of a subset of 102 participants who also completed neurocognitive tasks, comorbidity status was correctly predicted in 86.67% of participants (sensitivity: 91.67%; specificity: 66.67%) based on depressive symptoms and fear-related attentional bias. However, a regression-based analysis did not identify fear-related attentional bias as a splitting factor, but instead split and categorized the sample based on indices of aggression, metacognition, distress tolerance, and interoceptive awareness. These data indicate that within a population of individuals with SUD, aberrations in tolerating and regulating aversive internal experiences may also characterize those with significant trauma histories, akin to findings in persons with anxiety without SUD. The results also highlight the need for further research on PTSD-SUD comorbidity that includes additional comparison groups (i.e., persons with only PTSD), captures additional comorbid diagnoses that may influence the PTSD-SUD relationship, examines additional types of SUDs (e.g., alcohol use disorder), and differentiates between subtypes of PTSD.https://doi.org/10.1038/s41398-023-02591-3
spellingShingle David C. Houghton
Heidi M. Spratt
Lori Keyser-Marcus
James M. Bjork
Gretchen N. Neigh
Kathryn A. Cunningham
Tatiana Ramey
F. Gerard Moeller
Behavioral and neurocognitive factors distinguishing post-traumatic stress comorbidity in substance use disorders
Translational Psychiatry
title Behavioral and neurocognitive factors distinguishing post-traumatic stress comorbidity in substance use disorders
title_full Behavioral and neurocognitive factors distinguishing post-traumatic stress comorbidity in substance use disorders
title_fullStr Behavioral and neurocognitive factors distinguishing post-traumatic stress comorbidity in substance use disorders
title_full_unstemmed Behavioral and neurocognitive factors distinguishing post-traumatic stress comorbidity in substance use disorders
title_short Behavioral and neurocognitive factors distinguishing post-traumatic stress comorbidity in substance use disorders
title_sort behavioral and neurocognitive factors distinguishing post traumatic stress comorbidity in substance use disorders
url https://doi.org/10.1038/s41398-023-02591-3
work_keys_str_mv AT davidchoughton behavioralandneurocognitivefactorsdistinguishingposttraumaticstresscomorbidityinsubstanceusedisorders
AT heidimspratt behavioralandneurocognitivefactorsdistinguishingposttraumaticstresscomorbidityinsubstanceusedisorders
AT lorikeysermarcus behavioralandneurocognitivefactorsdistinguishingposttraumaticstresscomorbidityinsubstanceusedisorders
AT jamesmbjork behavioralandneurocognitivefactorsdistinguishingposttraumaticstresscomorbidityinsubstanceusedisorders
AT gretchennneigh behavioralandneurocognitivefactorsdistinguishingposttraumaticstresscomorbidityinsubstanceusedisorders
AT kathrynacunningham behavioralandneurocognitivefactorsdistinguishingposttraumaticstresscomorbidityinsubstanceusedisorders
AT tatianaramey behavioralandneurocognitivefactorsdistinguishingposttraumaticstresscomorbidityinsubstanceusedisorders
AT fgerardmoeller behavioralandneurocognitivefactorsdistinguishingposttraumaticstresscomorbidityinsubstanceusedisorders